Ruhr University Bochum
Bochum, 44625, Germany
NCT Number: NCT02330471
In a randomized clinical trial of 120 women undergoing large loop excision of the transformation zone (LLETZ)-conization for cervical dysplasia, two coagulation modes, spray versus forced coagulation, will be compared. The primary outcome of the study is time to complete hemostasis, secondary outcomes are intraoperative blood loss, postoperative pain, and postoperative bleeding complications.
Looking for future studies?
Notify Me18 year–80 year
Female
Interventional
Phase 3
Bochum, 44625, Germany
Intraoperative bleeding during large loop excision of the transformation zone (LLETZ)-conization can be achieved by two modes of electrocoagulation, spray coagulation and forced coagulation. Spray coagulation is a superficial coagulation mode, whereas forced coagulation is a deep tissue coagulation mode. It is unknown, whether spray or forced coagulation is superior regarding intraoperative hemostasis and other outcome Parameters such as postoperative bleeding and postoperative pain. Therefore, the investigator designed a randomized clinical trial of 120 women undergoing large loop excision of the transformation zone (LLETZ)-conization for cervical dysplasia, comparing the two coagulation modes, spray coagulation and forced coagulation, The primary outcome of the study is time to complete hemostasis measured in seconds, secondary outcomes are intraoperative blood loss measured as difference in serum hemoglobin pre- and postoperatively, postoperative pain according to a 10 step VAS scale, and postoperative bleeding complications, defined as necessity to intervene surgically for vaginal bleeding up to 14 days postoperatively. The study Population consists of women undergoing LLETZ-conization for histologically proven cervical dysplasia. The study hypothesis states that the difference in the mean time until complete hemostais will be at least 1/3 shorter in women randomized to spray coagulation. With a study Population of 120 women, this study has a power of >80% to detect a difference of 1/3 of the mean coagulation time until complete hemostais based on an anticipated mean time of 85 seconds.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
surgical method to achieve intraoperative hemostasis by a superficial electrocoagulation of 80 Watt voltage
surgical method to achieve intraoperative hemostasis by a deep tissue electrocoagulation of 80 Watt voltage
Time frame: 120 seconds
the time until complete hemostasis as judged by the surgeon has been achieved, will be measured in seconds
Time frame: 5 hours
patients will score their postoperative pain Level using a 10-step visual analogue scale (VAS) within 5 hours after surgery
Time frame: 14 days
postoperative complications defined as the necessity to intervene surgically for vaginal bleeding within 14 days after surgery
Time frame: 5 hours
intraoperative blood loss will be measured using the difference in serum hemoglobin one day prior to surgery and within 5 hours postoperatively
Ruhr University of Bochum
Other
Acronym: CONE-1
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01639820
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Bron, France
View Trial DetailsNCT03763565
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Bangkok, Thailand
View Trial DetailsNCT04415840
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Dortmund, North Rhine-Westphalia, Germany
View Trial DetailsNCT04326049
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Herne, North Rhine-Westphalia, Germany
View Trial Details